Keli Walbert insider trades

Open-market stock purchases and sales by Keli Walbert, Unknown at Hemab Therapeutics Holdings, Inc, from SEC Form 4 filings since Jan 8, 2025.

Recent trades

DateStockTradeValue
Sep 24, 2026COAG Hemab Therapeutics Holdings, IncBought (not open market)—
May 21, 2026SPRB Spruce Biosciences, IncBought (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$369K
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$508K
Jan 1, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
Jan 1, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
Dec 11, 2025SPRB Spruce Biosciences, IncBought (not open market)—

Companies traded

  • COAG Hemab Therapeutics Holdings, Inc: other filings, last Sep 24, 2026
  • SPRB Spruce Biosciences, Inc: other filings, last May 21, 2026
  • APLS Apellis Pharmaceuticals, Inc: other filings, last May 14, 2026

Get free alerts when Keli Walbert files a new trade →